Cyclacel Pharmaceuticals CEO Spiro Rombotis receives $1.8M in 2006
Cyclacel Pharmaceuticals reports 2006 executive compensation
By ExecPay News
Published: April 5, 2007
Cyclacel Pharmaceuticals reported fiscal year 2006 executive compensation information on April 5, 2007.
In 2006, seven executives at Cyclacel Pharmaceuticals received on average a compensation package of $814K.
Average pay of disclosed executives at Cyclacel Pharmaceuticals
Spiro Rombotis, Chief Executive Officer, received $1.8M in total. 73% of Rombotis' compensation, or $1.3M, was in option awards. Rombotis also received $175K in bonus, $300K in salary, as well as $21K in other compensation.
Paul McBarron, Chief Operating Officer, received a compensation package of $1.2M. 71% of the compensation package, or $835K, was in option awards.
Judy Chiao, Vice President Clinical Development and Regulatory Affairs, earned $970K in 2006.
John F. Womelsdorf, Vice President, Business Development, received $683K in 2006.
Robert C Jackson, Chief Scientific Officer, earned $415K in 2006.
Robert Kirkman, Chief Executive Officer, received $388K in 2006.
Kathi L. Cordova, Former Senior Vice President of Finance and Treasurer, earned $251K in 2006.
Related executives
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
Paul McBarron
Cyclacel Pharmaceuticals
Chief Financial Officer
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
Robert Jackson
Cyclacel Pharmaceuticals
Chief Scientific Officer
Robert Kirkman
Cyclacel Pharmaceuticals
Chief Executive Officer
Kathi Cordova
Cyclacel Pharmaceuticals
Former Senior Vice President of Finance and Treasurer
You may also like
Source: SEC filing on April 5, 2007.